Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

e AP (10/22, Balsamo, Sweet) reports, "Goldman Sachs Malaysia entered the plea in federal court in Brooklyn." The New York Timing (10/22, Goldstein, Flitter, 18.61M) says Goldman "admitted its Malaysian subsidiary 'knowingly and willingly' conspired to violate the Foreign Corrupt Practices Act because s

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

deral court in Brooklyn." The New York Times <https://www.nytimes.corn/2020/10/22/business/goldman-sachs-fraud-guilty-plea.html> (10/22, Goldstein, Flitter, 18.61M) says Goldman "admitted its Malaysian subsidiary `knowingly and willingly' conspired to violate the Foreign Corrupt Practices Act because so

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

he AP (10/22, Balsamo, Sweet) reports, "Goldman Sachs Malaysia entered the plea in federal court in Brooklyn." The New York Times (10/22, Goldstein, Flitter, 18.61M) says Goldman "admitted its Malaysian subsidiary `knowingly and willingly' conspired to violate the Foreign Corrupt Practices Act because s